Peter Attia· MD
full circle lowgrade prostate cancer guy comes in his T is 600 guy comes in you're supplementing his T to 600 to me you should follow them both carefully and in the same way
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
full circle lowgrade prostate cancer guy comes in his T is 600 guy comes in you're supplementing his T to 600 to me you should follow them both carefully and in the same way
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
so in my mind it's no different very interesting than than the other than anybody else you know who's within that normal distribution so it it is a radical thing but if you just think about it it's actually not it's not that radical really at all